Evidence map›Paper›PMID 34905563›Full record

ArticlePloS one2021

Understanding the social drivers of antibiotic use during COVID-19 in Bangladesh: Implications for reduction of antimicrobial resistance.

Abul Kalam, Shahanaj Shano, Mohammad Asif Khan, Ariful Islam, Narelle Warren, Mohammad Mahmudul Hassan, Mark Davis

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 31 citations in OpenAlex.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Abul KalamBangladesh Country Office, Helen Keller International, Dhaka, Bangladesh.ORCID 0000-0003-4236-8519
Shahanaj ShanoInstitute of Epidemiology, Disease Control and Research (IEDCR), Dhaka, Bangladesh.
Mohammad Asif KhanChattogram Civil Surgeon Office, Chattogram, Bangladesh.
Ariful IslamEcoHealth Alliance, New York, New York, United States of America.
Narelle WarrenSchool of Social and Political Sciences, Monash University, Melbourne, Victoria, Australia.
Mohammad Mahmudul HassanChittagong Veterinary and Animal Science University, Chattogram, Bangladesh.ORCID 0000-0001-6495-4637
Mark DavisSchool of Social and Political Sciences, Monash University, Melbourne, Victoria, Australia.
Monash University · AUChattogram Veterinary and Animal Sciences University · BDEcoHealth Alliance · USInstitute of Epidemiology, Disease Control and Research · BD

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Antimicrobial resistance (AMR) is a global public health crisis that is now impacted by the COVID-19 pandemic. Little is known how COVID-19 risks influence people to consume antibiotics, particularly in contexts like Bangladesh where these pharmaceuticals can be purchased without a prescription. This paper identifies the social drivers of antibiotics use among home-based patients who have tested positive with SARS-CoV-2 or have COVID-19-like symptoms. Using qualitative telephone interviews, the research was conducted in two Bangladesh cities with 40 participants who reported that they had tested positive for coronavirus (n = 20) or had COVID-19-like symptoms (n = 20). Our analysis identified five themes in antibiotic use narratives: antibiotics as 'big' medicine; managing anxiety; dealing with social repercussions of COVID-19 infection; lack of access to COVID-19 testing and healthcare services; and informal sources of treatment advice. Antibiotics were seen to solve physical and social aspects of COVID-19 infection, with urgent ramifications for AMR in Bangladesh and more general implications for global efforts to mitigate AMR.

Indexed as

Drug Resistance, BacterialAdultAnti-Bacterial AgentsAntimicrobial StewardshipBangladeshCOVID-19FemaleHumansMaleMiddle AgedPandemicsQualitative ResearchSocial FactorsAnti-Bacterial Agents

Identifiers

PMID34905563
PMCPMC8670684
OpenAlexW4200103521

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.